巴克洛芬不会增加脊髓融合后并发症的风险
Kenneth H Levy1, Burt Yaszay2, Mark F Abel3
1Department of Orthopaedic Surgery, The Johns Hopkins Hospital University, Baltimore, MD, USA.
Spine deformity
|November 25, 2023
概括
脑 (CP) 患者的脑内巴克洛芬 (ITB) 在经历后脊髓融合 (PSF) 的患者中显示出类似的并发症风险,无论是在手术前还是手术期间植入. CP 患者可以在没有增加风险的情况下安全地与 PSF 一起接受 ITB .
科学领域:
- 神经外科 神经外科
- 整形外科手术 整形外科手术
- 儿科神经学 儿科神经学
背景情况:
- 大脑 (CP) 通常涉及性,需要管理策略.
- 导管内巴克洛芬 (ITB) 用于管理严重的性.
- 后脊柱融合 (PSF) 是 CP 中脊柱形的常见手术干预.
研究的目的:
- 评估在接受PSF的CP患者中ITB的并发症风险.
- 根据ITB植入时间相对于PSF的时间来比较并发症率.
主要方法:
- 一个前性收集的多中心数据库 (2008-2023) 的回顾性审查.
- 使用ITB的患者 (ITB队列) 与没有使用ITB的患者 (非ITB队列) 的比较.
- 基于位的ITB队列的子组分析:在PSF之前或期间.
主要成果:
- 在ITB和非ITB队列之间,无明显的外科并发症或修复手术率的显著差异.
- 在PSF之前和PSF期间放置的ITB的并发症率相似.
- 在PSF期间植入时,观察到更长的手术时间.
结论:
- 在接受PSF的CP患者中,无论时间如何,ITB植入是安全的.
- 对于在PSF之前或期间放置的ITB,存在类似的并发症概况.
- ITB可以安全地集成到治疗性CP患者的治疗中.
相关概念视频
Local Anesthetics: Clinical Application as Spinal Anesthesia
639
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
639
Drug Delivery: Parenteral Route
557
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
557
Skeletal Muscle Relaxants: Therapeutic Uses
488
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
488
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Skeletal Muscle Relaxants: Adverse Effects
375
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
375
Centrally Acting Muscle Relaxants: Therapeutic Uses
696
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
696


